Similarly, metastatic renal cell carcinoma patients treated with CAR-T cells targeting carboxy-anhydrase-IX (CAIX) developed cholangitis due to the on-target but off-tumor toxicity such as the destruction of CAIX-expressing bile duct epithelial cells [30]. Here, CA9 is linked to cholangitis.